If there’s a silver lining to the COVID pandemic, it might be that it encourages U.S. manufacturers to consider reshoring. Last year’s shortages of personal protective equipment, ventilators, pharmaceutical ingredients and other medical products opened a lot of eyes in board rooms and in Washington.
In February, President Biden issued an executive order requiring his administration to review critical supply chains with the aim of bolstering American manufacturing of semiconductors, pharmaceuticals and other technologies.